Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence trends of pediatric onset inflammatory bowel disease in the years 2000-2009 in Saxony, Germany-first results of the Saxon Pediatric IBD Registry.
Kern I, Schoffer O, Kiess W, Henker J, Laaß MW, Winkler U, Quietzsch J, Wenzel O, Zurek M, Büttner K, Fischer P, de Laffolie J, Manuwald U, Stange T, Zenker R, Weidner J, Zimmer KP, Kunath H, Kugler J, Richter T, Rothe U. Kern I, et al. Among authors: stange t. PLoS One. 2021 Jan 4;16(1):e0243774. doi: 10.1371/journal.pone.0243774. eCollection 2021. PLoS One. 2021. PMID: 33395450 Free PMC article.
Incidence of childhood diabetes in children aged less than 15 years and its clinical and metabolic characteristics at the time of diagnosis: data from the Childhood Diabetes Registry of Saxony, Germany.
Galler A, Stange T, Müller G, Näke A, Vogel C, Kapellen T, Bartelt H, Kunath H, Koch R, Kiess W, Rothe U; Childhood Diabetes Registry in Saxony, Germany. Galler A, et al. Among authors: stange t. Horm Res Paediatr. 2010;74(4):285-291. doi: 10.1159/000303141. Epub 2010 May 28. Horm Res Paediatr. 2010. PMID: 20516654
Trends in Incidence Rates during 1999-2008 and Prevalence in 2008 of Childhood Type 1 Diabetes Mellitus in Germany--Model-Based National Estimates.
Bendas A, Rothe U, Kiess W, Kapellen TM, Stange T, Manuwald U, Salzsieder E, Holl RW, Schoffer O, Stahl-Pehe A, Giani G, Ehehalt S, Neu A, Rosenbauer J. Bendas A, et al. Among authors: stange t. PLoS One. 2015 Jul 16;10(7):e0132716. doi: 10.1371/journal.pone.0132716. eCollection 2015. PLoS One. 2015. PMID: 26181330 Free PMC article.
Is ultraviolet exposure acquired at work the most important risk factor for cutaneous squamous cell carcinoma? Results of the population-based case-control study FB-181.
Schmitt J, Haufe E, Trautmann F, Schulze HJ, Elsner P, Drexler H, Bauer A, Letzel S, John SM, Fartasch M, Brüning T, Seidler A, Dugas-Breit S, Gina M, Weistenhöfer W, Bachmann K, Bruhn I, Lang BM, Bonness S, Allam JP, Grobe W, Stange T, Westerhausen S, Knuschke P, Wittlich M, Diepgen TL; FB-181 Study Group. Schmitt J, et al. Among authors: stange t. Br J Dermatol. 2018 Feb;178(2):462-472. doi: 10.1111/bjd.15906. Epub 2018 Jan 15. Br J Dermatol. 2018. PMID: 28845516
Occupational UV-Exposure is a Major Risk Factor for Basal Cell Carcinoma: Results of the Population-Based Case-Control Study FB-181.
Schmitt J, Haufe E, Trautmann F, Schulze HJ, Elsner P, Drexler H, Bauer A, Letzel S, John SM, Fartasch M, Brüning T, Seidler A, Dugas-Breit S, Gina M, Weistenhöfer W, Bachmann K, Bruhn I, Lang BM, Bonness S, Allam JP, Grobe W, Stange T, Westerhausen S, Knuschke P, Wittlich M, Diepgen TL; FB 181 Study Group. Schmitt J, et al. Among authors: stange t. J Occup Environ Med. 2018 Jan;60(1):36-43. doi: 10.1097/JOM.0000000000001217. J Occup Environ Med. 2018. PMID: 29111985
Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
Beyer-Westendorf J, Lützner J, Donath L, Tittl L, Knoth H, Radke OC, Kuhlisch E, Stange T, Hartmann A, Günther KP, Weiss N, Werth S. Beyer-Westendorf J, et al. Among authors: stange t. Thromb Haemost. 2013 Jan;109(1):154-63. doi: 10.1160/TH12-07-0510. Epub 2012 Nov 29. Thromb Haemost. 2013. PMID: 23197272
Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care--results from the Dresden NOAC registry.
Beyer-Westendorf J, Gelbricht V, Förster K, Ebertz F, Röllig D, Schreier T, Tittl L, Thieme C, Hänsel U, Köhler C, Werth S, Kuhlisch E, Stange T, Röder I, Weiss N. Beyer-Westendorf J, et al. Among authors: stange t. Br J Clin Pharmacol. 2014 Oct;78(4):908-17. doi: 10.1111/bcp.12391. Br J Clin Pharmacol. 2014. PMID: 24697922 Free PMC article.
40 results